• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜中磷酸化的α-突触核蛋白是帕金森病病理严重程度的生物标志物。

Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

机构信息

Department of Physiology, Genetics and Microbiology, University of Alicante, Spain.

Banner Sun Health Research Institute, Sun City, Arizona, USA.

出版信息

Mov Disord. 2018 Aug;33(8):1315-1324. doi: 10.1002/mds.27392. Epub 2018 May 8.

DOI:10.1002/mds.27392
PMID:29737566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6146055/
Abstract

BACKGROUND

PD patients often have visual alterations, for example, loss of visual acuity, contrast sensitivity or motion perception, and diminished electroretinogram responses. PD pathology is mainly characterized by the accumulation of pathological α-synuclein deposits in the brain, but little is known about how synucleinopathy affects the retina.

OBJECTIVE

To study the correlation between α-synuclein deposits in the retina and brain of autopsied subjects with PD and incidental Lewy body disease.

METHODS

We evaluated the presence of phosphorylated α-synuclein in the retina of autopsied subjects with PD (9 subjects), incidental Lewy body disease (4 subjects), and controls (6 subjects) by immunohistochemistry and compared the retinal synucleinopathy with brain disease severity indicators.

RESULTS

Whereas controls did not show any phosphorylated α-synuclein immunoreactivity in their retina, all PD subjects and 3 of 4 incidental Lewy body disease subjects had phosphorylated α-synuclein deposits in ganglion cell perikarya, dendrites, and axons, some of them resembling brain Lewy bodies and Lewy neurites. The Lewy-type synucleinopathy density in the retina significantly correlated with Lewy-type synucleinopathy density in the brain, with the Unified Parkinson's disease pathology stage and with the motor UPDRS.

CONCLUSION

These data suggest that phosphorylated α-synuclein accumulates in the retina in parallel with that in the brain, including in early stages preceding development of clinical signs of parkinsonism or dementia. Therefore, the retina may provide an in vivo indicator of brain pathology severity, and its detection could help in the diagnosis and monitoring of disease progression. © 2018 International Parkinson and Movement Disorder Society.

摘要

背景

PD 患者常出现视觉改变,例如视力下降、对比敏感度或运动知觉下降,以及视网膜电图反应减弱。PD 病理学主要表现为脑内病理性 α-突触核蛋白沉积,但对于突触核蛋白病如何影响视网膜知之甚少。

目的

研究尸检 PD 患者和偶发路易体病患者脑内 α-突触核蛋白沉积与视网膜之间的相关性。

方法

我们通过免疫组织化学方法评估了尸检 PD 患者(9 例)、偶发路易体病患者(4 例)和对照组(6 例)视网膜中磷酸化 α-突触核蛋白的存在,并将视网膜突触核蛋白病与脑疾病严重程度指标进行了比较。

结果

对照组视网膜中未显示任何磷酸化 α-突触核蛋白免疫反应性,而所有 PD 患者和 4 例偶发路易体病患者中有 3 例在神经节细胞胞体、树突和轴突中出现磷酸化 α-突触核蛋白沉积,其中一些类似于脑路易体和路易神经突。视网膜中的 Lewy 型突触核蛋白病密度与脑内 Lewy 型突触核蛋白病密度、帕金森病统一病理分期和运动 UPDRS 显著相关。

结论

这些数据表明,磷酸化 α-突触核蛋白在视网膜中的积累与脑内的积累平行,包括在出现帕金森病或痴呆的临床症状之前的早期阶段。因此,视网膜可能提供脑病理学严重程度的体内指标,其检测有助于诊断和监测疾病进展。

相似文献

1
Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.视网膜中磷酸化的α-突触核蛋白是帕金森病病理严重程度的生物标志物。
Mov Disord. 2018 Aug;33(8):1315-1324. doi: 10.1002/mds.27392. Epub 2018 May 8.
2
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.具有神经核蛋白病患者胰岛β细胞中淀粉样蛋白形成蛋白的相互作用。
Acta Neuropathol. 2018 Jun;135(6):877-886. doi: 10.1007/s00401-018-1832-0. Epub 2018 Mar 13.
3
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].帕金森病与路易体痴呆早期诊断的临床与病理研究
Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. doi: 10.5692/clinicalneurol.48.11.
4
Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.帕金森病、路易体痴呆及其他路易体疾病中下颌下腺突触核蛋白病的患病率
J Parkinsons Dis. 2016;6(1):153-63. doi: 10.3233/JPD-150680.
5
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.CD8 T 细胞在帕金森病早期就已经浸润黑质,且早于突触核蛋白病出现。
Brain. 2020 Dec 1;143(12):3717-3733. doi: 10.1093/brain/awaa269.
6
A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.对路易体疾病中α-突触核蛋白病理学当前分期的批判性评估。
Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5.
7
Spinal cord lesions in sporadic Parkinson's disease.散发性帕金森病的脊髓病变。
Acta Neuropathol. 2012 Nov;124(5):643-64. doi: 10.1007/s00401-012-1028-y. Epub 2012 Aug 29.
8
Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.帕金森病和路易体痴呆中 α-突触核蛋白病理对岛叶皮质亚区的差异性易损性。
Neuropathol Appl Neurobiol. 2019 Apr;45(3):262-277. doi: 10.1111/nan.12501. Epub 2018 Jun 26.
9
Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.散发性路易体病和帕金森病中黑质神经元丢失的分期依赖性
Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952. Epub 2014 Jul 3.
10
Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients.帕金森病和路易体痴呆患者尸检脑组织中 SIDT2 水平和定位的病理学相关变化。
Neurochem Int. 2022 Jan;152:105243. doi: 10.1016/j.neuint.2021.105243. Epub 2021 Nov 18.

引用本文的文献

1
Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders.神经疾病中视觉功能障碍与眼部生物标志物的最新进展
Eye Brain. 2025 Jun 14;17:49-67. doi: 10.2147/EB.S516393. eCollection 2025.
2
Redefining Non-Motor Symptoms in Parkinson's Disease.重新定义帕金森病的非运动症状
J Pers Med. 2025 Apr 26;15(5):172. doi: 10.3390/jpm15050172.
3
Keeping an eye on Parkinson's disease: color vision and outer retinal thickness as simple and non-invasive biomarkers.关注帕金森病:色觉和视网膜外层厚度作为简单且无创的生物标志物
J Neurol. 2025 Apr 21;272(5):351. doi: 10.1007/s00415-025-13080-6.
4
Optical coherence tomography reveals retinal structural abnormalities in α-synucleinopathies: insights from the Padua-CESNE cohort.光学相干断层扫描揭示α-突触核蛋白病中的视网膜结构异常:来自帕多瓦- CESNE队列的见解。
J Neural Transm (Vienna). 2025 Apr 15. doi: 10.1007/s00702-025-02918-y.
5
A Narrative Review on Biochemical Markers and Emerging Treatments in Prodromal Synucleinopathies.前驱性突触核蛋白病的生化标志物与新兴治疗方法的叙述性综述
Clin Pract. 2025 Mar 17;15(3):65. doi: 10.3390/clinpract15030065.
6
Artificial intelligence in stroke risk assessment and management via retinal imaging.通过视网膜成像进行中风风险评估与管理的人工智能
Front Comput Neurosci. 2025 Feb 17;19:1490603. doi: 10.3389/fncom.2025.1490603. eCollection 2025.
7
The role of RGC degeneration in the pathogenesis of glaucoma.视网膜神经节细胞变性在青光眼发病机制中的作用。
Int J Biol Sci. 2025 Jan 1;21(1):211-232. doi: 10.7150/ijbs.103222. eCollection 2025.
8
Posttranslational Modifications of -Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.- 突触核蛋白的翻译后修饰、它们的治疗潜力,以及在健康和神经退行性疾病中的相互作用。
Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111.
9
Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.神经退行性疾病死后视网膜的神经病理学特征。
Acta Neuropathol. 2024 Aug 19;148(1):24. doi: 10.1007/s00401-024-02769-z.
10
Neuroretinal and microvascular retinal features in dementia with Lewy body assessed by optical coherence tomography angiography.通过光学相干断层扫描血管造影评估路易体痴呆中的神经视网膜和视网膜微血管特征。
Neurol Sci. 2025 Jan;46(1):185-194. doi: 10.1007/s10072-024-07683-6. Epub 2024 Aug 17.

本文引用的文献

1
Early Corneal Innervation and Trigeminal Alterations in Parkinson Disease: A Pilot Study.帕金森病早期角膜神经支配及三叉神经改变:一项初步研究。
Cornea. 2018 Apr;37(4):448-454. doi: 10.1097/ICO.0000000000001517.
2
Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond.阿尔茨海默病、帕金森病及其他疾病中的视网膜神经节细胞与昼夜节律
Front Neurol. 2017 May 4;8:162. doi: 10.3389/fneur.2017.00162. eCollection 2017.
3
Loss of Melanopsin-Expressing Ganglion Cell Subtypes and Dendritic Degeneration in the Aging Human Retina.衰老人类视网膜中表达黑视蛋白的神经节细胞亚型的丧失和树突退化
Front Aging Neurosci. 2017 Apr 4;9:79. doi: 10.3389/fnagi.2017.00079. eCollection 2017.
4
Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease.患有阿尔茨海默病的受试者眼部不存在阿尔茨海默病神经病理变化。
J Neuropathol Exp Neurol. 2017 May 1;76(5):376-383. doi: 10.1093/jnen/nlx020.
5
Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease.帕金森病患者进行性视觉功能障碍和视网膜变性的评估
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1151-1157. doi: 10.1167/iovs.16-20460.
6
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease.寻找帕金森病α-突触核蛋白病理学的外周活检指标
J Neuropathol Exp Neurol. 2017 Jan 1;76(1):2-15. doi: 10.1093/jnen/nlw103.
7
Reduction of GAPDH in lenses of Parkinson's disease patients: A possible new biomarker.帕金森病患者晶状体中甘油醛-3-磷酸脱氢酶水平降低:一种可能的新生物标志物。
Mov Disord. 2017 Mar;32(3):459-462. doi: 10.1002/mds.26863. Epub 2016 Nov 10.
8
Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness.医学中的定量体液蛋白质组学——聚焦微创性。
J Proteomics. 2017 Feb 5;153:30-43. doi: 10.1016/j.jprot.2016.08.009. Epub 2016 Aug 16.
9
Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.帕金森病/路易体痴呆转基因小鼠模型中视网膜α-突触核蛋白::GFP 沉积的纵向活体成像。
Sci Rep. 2016 Jul 8;6:29523. doi: 10.1038/srep29523.
10
Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers.阿尔茨海默病患者泪液化学屏障成分的变化揭示了潜在的泪液诊断生物标志物。
PLoS One. 2016 Jun 21;11(6):e0158000. doi: 10.1371/journal.pone.0158000. eCollection 2016.